F atigue is common and debilitating, reported by more than 80% of patients with active inflammatory bowel disease (IBD) and 40% with quiescent disease. 1, 2 The etiology is complex and incompletely understood. Studies have suggested links between fatigue, IBD activity, and various psychological factors. [3] [4] [5] [6] We assessed the relationship between fatigue and clinical and biochemical disease activity, as well as factors including mood, somatization, and the presence of irritable bowel syndrome (IBS)-type symptoms. We hypothesized that there would be no correlation between fatigue and objective markers of disease activity, rather than that fatigue would be associated with low mood, somatoform behavior, and symptom reporting in general.
Methods
We performed a cross-sectional study of outpatients with IBD at Leeds Teaching Hospitals National Health Service Trust, UK, between December 2016 and April 2017. All patients received study information and provided written informed consent. They provided blood for hemoglobin and stool for fecal calprotectin (FC) measurements (Immundiagnostik, Bensheim, Germany). Patient demographics and disease characteristics were collected. Fatigue was assessed using the IBD fatigue self-assessment scale, 7 consisting of 2 sections. Section one assesses frequency and severity of fatigue, and section 2 assesses the impact of fatigue on daily activities. Higher scores represent higher fatigue severity, and greater impact on daily life. We used validated questionnaires assessing co-existent IBS-type symptoms (Rome III), clinical disease activity (Harvey-Bradshaw index for Crohn's disease and simple clinical colitis activity index for ulcerative colitis), mood (hospital anxiety and depression scale), and somatization-type behavior (patient health questionnaire-15). The study was approved by the local research ethics committee (reference number: 16/YH/0235).
The Student t test was used to compare mean fatigue severity and impact scores across various clinical and psychological factors. Correlation between fatigue scores and both hemoglobin and FC levels, as continuous variables, was analyzed using the Pearson correlation coefficient. P values less than .05 were considered statistically significant. All analyses were performed using SPSS for Windows version 23.0 (SPSS, Inc, Chicago, IL).
Results
Seventy-one IBD patients were recruited (mean age, 37.4 y; 49 [69.0%] women). Fifty-two (73.2%) had Crohn's disease, 19 (26.8%) had ulcerative colitis, and 43 (60.6%) had quiescent disease according to clinical disease activity indices. The mean fatigue scores according to patient characteristics are summarized in Table 1 . Patients with clinically active disease reported higher fatigue severity and impact compared with patients in clinical remission (P ¼ .047 and P ¼ .01, respectively). However, there was no correlation between fatigue severity (r ¼ 0.16; P ¼ .28) or impact (r ¼ 0.10; P ¼ .49) and FC levels, and no difference according to normal or abnormal FC levels.
Patients with abnormal anxiety scores reported higher fatigue severity (P ¼ .001) and impact (P < .001). There was no difference in fatigue severity between patients with normal and abnormal depression scores (P ¼ .28). However, fatigue impact scores were higher in those with abnormal depression scores (P ¼ .004). Patients reporting IBS-type symptoms had greater fatigue severity (P ¼ .01), but there was no difference in fatigue impact (P ¼ .08). High levels of somatization were strongly associated with both greater fatigue severity and impact scores (P < .001 for both). Fatigue scores did not differ in those with or without anemia, or according to hemoglobin levels (fatigue severity: r ¼ -0.167, P ¼ .18; and fatigue impact: r ¼ -0.129, P ¼ .30).
Discussion
This study shows that patients with IBD with clinically active disease report greater fatigue severity and impact. However, there was no correlation between fatigue and FC levels. In addition, abnormal anxiety scores and high levels of somatization were strongly associated with greater levels of fatigue severity and impact. Patients with abnormal depression scores reported a greater impact of fatigue on daily activities, and those with IBS-type symptoms reported higher fatigue severity. Finally, fatigue scores did not differ according to hemoglobin level or presence of anemia.
These findings confirm the multifactorial etiology of fatigue, and the significant impact of psychological factors. The fact that higher fatigue scores were associated with clinical disease activity scores, mood scores, high levels of somatization, and presence of IBS-type symptoms, but not biochemical evidence of IBD activity, supports previous observations that disease activity scores do not always reflect genuine mucosal inflammation, but rather are influenced by psychological comorbidities that also may be prevalent in IBD patients. 8 Our results also suggest that fatigue reporting may relate more to poor psychological health, and willingness to endorse symptoms referable to multiple body systems, rather than arising as a direct consequence of mucosal inflammation or anemia. To improve fatigue in IBD, interventional studies focusing on improving psychological well-being are required. 
